Hepatitis C by Donald JensenHepatitis C by Donald Jensen

Hepatitis C

EditorDonald Jensen, Nancy Reau

Paperback | December 27, 2012

Pricing and Purchase Info

$31.74 online 
$38.95 list price save 18%
Earn 159 plum® points

Prices and offers may vary in store


Ships within 1-3 weeks

Ships free on orders over $25

Not available in stores


Rapid and profound changes are taking place in the field of hepatitis C therapeutics. More than ever, these changes necessitate a current, clinically pertinent review of the broader scope of hepatitis C, including its epidemiology, diagnosis, natural history, and clinical features. Thishandbook provides that concise survey of the field. Acute and chronic hepatitis C are addressed as are important new treatment options for hepatitis C, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C. Part of the Oxford AmericanInfectious Disease Library, this evidence-based clinical resource will appeal to clinicians directly involved in the care of patients with hepatitis C.
Donald Jensen is Professor of Medicine and Director at the Center for Liver Disease at University of Chicago Medical Center. Nancy Reau is Associate Professor of Medicine at the Center for Liver Disease at University of Chicago Medical Center.
Title:Hepatitis CFormat:PaperbackDimensions:176 pages, 8 × 5 × 0.68 inPublished:December 27, 2012Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0199844291

ISBN - 13:9780199844296

Look for similar items by category:


Table of Contents

1. Basic Virology2. Epidemiology of Hepatitis3. Natural History of Hepatitis4. Diagnostic Testing5. Pathology of Viral Hepatitis6. Acute Hepatitis7. Chonic Hepatitis8. Extrahepatic Manifestations of Hepatitis9. Hepatitis C in Liver Transplantation10. Treatment of Hepatitis11. Side Effect Management of Peginterferon and Ribavirin12. Hepatitis C in Special Populations13. New Treatments: Telaprevir and Boceprevir14. HCV Directly Acting Antiviral Therapies (Other than Boceprevir and Telaprevir)15. Lexicon of Trials for Treatment of Chronic Hepatitis CAppendix